Replies to post #14513 on Cytodyn Inc (CYDY)

[Northstar42]

Current SP makes raising capital problematic to say the least, so that's the bad news. The good news is that the current SP because it makes raising capital problematic means that management will have to do cut a deal very soon or risk having to shut down the trials. Of course, deals made under duress never yield the return shareholders would like, but I for one, would be happy to settle for $3.00 - $4.00/share BO with the assurance that PRO 140 is made available to patients as quickly as possible.